Suppr超能文献

巴尔的摩市两个基层康复项目中丁丙诺啡治疗阿片类药物依赖成功的预测因素。

Predictors of buprenorphine treatment success of opioid dependence in two Baltimore City grassroots recovery programs.

作者信息

Damian April Joy, Mendelson Tamar, Agus Deborah

机构信息

Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 624 North Broadway Street, Room 798, Baltimore, MD 21205, United States.

Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 624 North Broadway Street, Room 853, Baltimore, MD 21205, United States.

出版信息

Addict Behav. 2017 Oct;73:129-132. doi: 10.1016/j.addbeh.2017.05.010. Epub 2017 May 10.

Abstract

INTRODUCTION

Despite evidence for the efficacy of buprenorphine treatment in primary care, few studies have identified factors associated with treatment success, nor have such factors been evaluated in community settings. Identifying correlates of treatment success can facilitate the development of treatment models tailored for distinct populations, including low-income communities of color. The current study examined client-level socio-demographic factors associated with treatment success in community-based buprenorphine programs serving vulnerable populations.

METHODS

Data were abstracted from client records for participants (N=445) who met DSM-IV criteria for opioid dependence and sought treatment at one of Behavioral Health Leadership Institute's two community-based recovery programs in Baltimore City from 2010 to 2015. Logistic regression estimated the odds ratios of treatment success (defined as retention in treatment for ≥90days) by sociodemographic predictors including age, race, gender, housing, legal issues and incarceration.

RESULTS

The odds of being retained in treatment ≥90days increased with age (5% increase with each year of age; p<0.001), adjusting for other sociodemographic factors. Clients who reported unstable housing had a 41% decreased odds of remaining in treatment for 90 or more days compared to clients who lived independently at intake. Treatment success did not significantly differ by several other client-level characteristics including gender, race, employment, legal issues and incarceration.

CONCLUSIONS

In vulnerable populations, the age factor appears sufficiently significant to justify creating models formulated for younger populations. The data also support attention to housing needs for people in treatment. Findings from this paper can inform future research and program development.

摘要

引言

尽管有证据表明丁丙诺啡治疗在初级保健中具有疗效,但很少有研究确定与治疗成功相关的因素,而且在社区环境中也未对这些因素进行评估。确定治疗成功的相关因素有助于开发针对不同人群(包括低收入有色人种社区)量身定制的治疗模式。本研究调查了在为弱势群体服务的社区丁丙诺啡项目中与治疗成功相关的个体层面社会人口学因素。

方法

数据取自符合阿片类药物依赖DSM-IV标准并于2010年至2015年期间在巴尔的摩市行为健康领导力研究所的两个社区康复项目之一寻求治疗的参与者(N = 445)的客户记录。逻辑回归通过社会人口学预测因素(包括年龄、种族、性别、住房、法律问题和监禁情况)估计治疗成功(定义为治疗持续≥90天)的优势比。

结果

在调整其他社会人口学因素后,治疗持续≥90天的几率随年龄增加而增加(年龄每增加一岁增加5%;p < 0.001)。报告住房不稳定的客户与入院时独立生活的客户相比,治疗90天或更长时间的几率降低了41%。治疗成功在其他几个个体层面特征(包括性别、种族、就业、法律问题和监禁情况)上没有显著差异。

结论

在弱势群体中,年龄因素似乎足够显著,足以证明为年轻人群体制定治疗模式是合理的。数据还支持关注治疗人群的住房需求。本文的研究结果可为未来的研究和项目开发提供参考。

相似文献

1
Predictors of buprenorphine treatment success of opioid dependence in two Baltimore City grassroots recovery programs.
Addict Behav. 2017 Oct;73:129-132. doi: 10.1016/j.addbeh.2017.05.010. Epub 2017 May 10.
6
A novel community-based buprenorphine program: client description and initial outcomes.
J Addict Med. 2014 Jan-Feb;8(1):40-6. doi: 10.1097/ADM.0000000000000004.
8
Long-term retention in Office Based Opioid Treatment with buprenorphine.
J Subst Abuse Treat. 2017 Mar;74:65-70. doi: 10.1016/j.jsat.2016.12.010. Epub 2016 Dec 30.

引用本文的文献

2
Medications for Opioid Use Disorder Among Transition Age Youth Compared to Adults 26 or Older in Rural Settings.
JAACAP Open. 2024 Feb 28;2(4):231-238. doi: 10.1016/j.jaacop.2024.02.001. eCollection 2024 Dec.
4
Low-dose buprenorphine initiation and treatment continuation among hospitalized patients with opioid dependence: A retrospective cohort study.
J Subst Use Addict Treat. 2024 Mar;158:209261. doi: 10.1016/j.josat.2023.209261. Epub 2023 Dec 14.
5
Recent Opioid Use Impedes Range Adaptation in Reinforcement Learning in Human Addiction.
Biol Psychiatry. 2024 May 15;95(10):974-984. doi: 10.1016/j.biopsych.2023.12.005. Epub 2023 Dec 13.
6
Outcomes from the medication assisted treatment pilot program for adults with opioid use disorders in rural Colorado.
Subst Abuse Treat Prev Policy. 2022 Jan 3;17(1):1. doi: 10.1186/s13011-021-00424-4.
7
Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder.
J Racial Ethn Health Disparities. 2022 Aug;9(4):1557-1567. doi: 10.1007/s40615-021-01095-4. Epub 2021 Jul 12.
8
Opioid use disorder treatment for people experiencing homelessness: A scoping review.
Drug Alcohol Depend. 2021 Jul 1;224:108717. doi: 10.1016/j.drugalcdep.2021.108717. Epub 2021 Apr 20.

本文引用的文献

1
Retention in medication-assisted treatment for opiate dependence: A systematic review.
J Addict Dis. 2016;35(1):22-35. doi: 10.1080/10550887.2016.1100960. Epub 2015 Oct 14.
2
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Cochrane Database Syst Rev. 2014 Feb 6;2014(2):CD002207. doi: 10.1002/14651858.CD002207.pub4.
3
A novel community-based buprenorphine program: client description and initial outcomes.
J Addict Med. 2014 Jan-Feb;8(1):40-6. doi: 10.1097/ADM.0000000000000004.
4
Medication-assisted treatment of opiate dependence is gaining favor.
Cleve Clin J Med. 2013 Jun;80(6):345-9. doi: 10.3949/ccjm.80a.12181.
5
Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.
Drug Alcohol Depend. 2013 Jul 1;131(1-2):112-8. doi: 10.1016/j.drugalcdep.2012.12.010. Epub 2013 Jan 18.
6
Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.
J Natl Med Assoc. 2012 Jul-Aug;104(7-8):342-50. doi: 10.1016/s0027-9684(15)30175-9.
8
The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment.
J Subst Abuse Treat. 2010 Dec;39(4):340-52. doi: 10.1016/j.jsat.2010.07.009.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验